Skip to main content
. 2019 Dec 12;20(24):6280. doi: 10.3390/ijms20246280

Figure 3.

Figure 3

Farnesiferol B protects kidney from I/R-induced inflammation. (A) Representative images and (B) the quantitative analysis of positive immunostaining for macrophages on renal sections from (a) sham, (b) I/R, (c) I/R + Farnesiferol B, and (d) sham + Farnesiferol B groups (scale bar 50 μm). (C) Representative images and (D) the quantitative analysis of positive immunostaining for neutrophils on renal sections from (a) sham, (b) I/R, (c) I/R + Farnesiferol B,  and (d) sham + Farnesiferol B groups (scale bar 50 μm). Levels of (E) serum TNFα, (F) kidney TNFα, (G) serum MCP-1, (H) kidney MCP-1, (I) kidney LTB4, (J) kidney TNFα mRNA, (K) kidney IL-6 mRNA, and (L) kidney Icam mRNA from different treatment groups. n = 6 mice/group. Data are means ± SD, one-way ANOVA with Bonferroni’s test. * p < 0.05.